tbuckley/cabot-search huggingface dataset:
Comprehensive Analysis of the Structural, Biochemical and Signaling Differences of the p210 and p185 Isoforms of Bcr-Abl in CML and B-ALL
Authors: Oliver Hantschel, Sina Reckel, Hamelin Romain, Florence Armand, Delphine Harduin, Shohei Koide, Volker Dötsch, Marc Moniatte
Journal: Blood (2016)
Pharmacokinetics for Once-Daily Modified Release Formulation Tacrolimus Hydrate in Unrelated Hematopoietic Stem Cell Transplantation.
Authors: Shingo Yano, Shin-ichiro Mori, Takeshi Saito, Hiroki Yokoyama, Tomohito Machishima, Katsuki Sugiyama, Yoji Ogasawara, Kinuyo Kasama, Noriko Usui, Keisuke Aiba, Takuya Yamashita
Journal: Blood (2012)
Influence of physical symptoms on distress in patients with colorectal cancer undergoing outpatient chemotherapy
Authors: Miwa Aoki, Harue Arao, Akiko Hatakeyama, Yoko Minamiguchi, Masayo Toki, Naomi Fujikawa, Kota Asano, Ayumi Takao, Yukiko Tatsumi
Journal: Annals of Oncology (2019)
Cases in Precision Medicine: <i>APOL1</i> and Genetic Testing in the Evaluation of Chronic Kidney Disease and Potential Transplant
Authors: Y. Dana Neugut, Sumit Mohan, Ali G. Gharavi, Krzysztof Kiryluk
Journal: Annals of Internal Medicine (2019)

This article discusses potential indications for genetic testing in an African American patient with chronic kidney disease who is being evaluated for a kidney transplant. Two known risk variants in the APOL1 (apolipoprotein L1) gene predispose to kidney disease and are found almost exclusively in persons of African ancestry. APOL1 risk variants are considered, including whether clinicians should incorporate genetic testing in the screening process for living kidney donors. In addition to APOL1 testing, the role of diagnostic exome sequencing in evaluating potential transplant recipients and donors with a positive family history of kidney disease is discussed.
Single-Agent Lenalidomide for Patients with Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma Who Had Received Prior Stem Cell Transplant.
Authors: Julie M. Vose, Thomas Habermann, Myron S Czuczman, Pier Luigi Zinzani, Craig B. Reeder, Joseph Tuscano, Izidore S Lossos, Dennis Pietronigro, Annette Ervin-Haynes, Thomas Witzig
Journal: Blood (2009)
Head-to-Head Comparison of 5-Azacitidine Versus Decitabine for the Treatment of Myelodysplastic Syndrome.
Authors: Yun-Gyoo Lee, Inho Kim, Sung-Soo Yoon, Seonyang Park, June-Won Cheong, Yoo-Hong Min, Soo-Mee Bang, Chul Soo Kim, Yong Park, Yeung Chul Mun, Jinny Park, Jae Hoon Lee, Hong Ghi Lee, Yeo-Kyeoung Kim, Hyeoung-Joon Kim
Journal: Blood (2012)
Serum Cytokine Profile in Patients with Septic Shock/Severe Sepsis and Thrombocytopenia
Authors: Panagiotis Tsirigotis, Konstantinos Gkirkas, Spiros Chondropoulos, Ioannis Papassotiriou, Anastasia Bartzeliotou, Christina Economopoulou, Maria Atta, Nikolaos Papanikolaou, Dikea-Eleni Ioannidou, Diamantina Vasilatou, Sotirios G Papageorgiou, Maria Stamouli, Vassiliki Pappa, Ioanna Dimopoulou
Journal: Blood (2014)
Young Paternal Age and Risk Of Infant Acute Lymphoblastic Leukemia
Authors: Julie A Ross, Todd E Druley, Kimberly J Johnson, Rachel K. Fonstad, Julie von Behren, Beth Mueller, Susan Carozza, Eric J. Chow, Colleen McLaughlin, Peggy Reynolds, Erin Fox, Scott Horel, Logan G. Spector
Journal: Blood (2013)
IPI, Comorbidity Index, Hospitalization for Treatment-Related Adverse Events Are Predictors for Outcome in Elderly Diffuse Large B Cell Lymphoma Patients
Authors: Caner Saygin, Xuefei Jia, Brian T. Hill, Robert M. Dean, Bhumika Patel, Brad Pohlman, Mitchell R. Smith, Deepa Jagadeesh
Journal: Blood (2016)
A Phase 2 study of the Combination of Omacetaxine and Imatinib in the Treatment of Patients with Chronic Myeloid Leukemia (CML) in Advanced Stages or After Failure to Imatinib.
Authors: Mohamad Ayoubi, Hagop M. Kantarjian, William Wierda, Alessandra Ferrajoli, Jody Hiteshew, Zeev Estrov, Jorge Cortes-Franco
Journal: Blood (2009)
Identification of Wee1 and IGF-1R As Novel Therapeutic Targets for Mutant RAS-Driven Acute Leukemia By Combinatory Chemical Screens
Authors: Atsushi Nonami, Chen Zhao, Liu Qingsong, Kristen Cowens, Amanda L. Christie, Yongfei Chen, Martin Sattler, Kwok-Kin Wang, Nathanael S. Gray, James D. Griffin, Ellen L. Weisberg
Journal: Blood (2014)
A Compendium of Cytogenetic Abnormalities in Myelofibrosis: Molecular and Phenotypic Correlates in 826 Patients
Authors: Emnet A Wassie, Christy Finke, Naseema Gangat, Terra L Lasho, Animesh Pardanani, Curtis A. Hanson, Ketterling Rhett, Ayalew Tefferi
Journal: Blood (2014)
Elastic Plasma-Protein-Film Blended with Platelet-Releasate Accelerates Healing of Diabetic Mouse Skin Wounds.
Authors: Ryuhei Tanaka, Shigeru Ichioka, Naomi Sekiya, Norihiko Ohura, Satomi Uchino, Ikue Ishikawa, Aki Ojima, Yoshihiro Itoh, Osamu Ishihara, Takashi Nakatsuka, Kenji Ikebuchi
Journal: Blood (2005)
Progress in Treating Youth Smoking: Imperative, Difficult, Slow
Authors: Megan E. Piper, Robin Mermelstein, Timothy B. Baker
Journal: JAMA Pediatrics (2019)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Pediatrics HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Pediatrics journal
Prognostic Significance of Ki-67 Expression in Extranodal NK/T Cell Lymphoma, Nasal Type: A Proposed Prognostic Index, KLABS Index.
Authors: Seok Jin Kim, Soo-Young Yoon, Byung Soo Kim, Chul Won Choi, Jungwoo Choi, In Sun Kim, Young-Hen Lee, Jun Suk Kim
Journal: Blood (2006)
The Spiegelmer® Nox-A12 Abrogates Homing Of Human CLL Cells To Bone Marrow and Mobilizes Murine CLL Cells In The Eμ-TCL1 Transgenic Mouse Model Of CLL
Authors: Elisabeth Hinterseer, Tamara Girbl, Evelyn Hutterer, Petra Berghammer, Sylvia Ganghammer, Eveline Sifft, Josefina Pinon Hofbauer, Alexander Egle, Anna Kruschinski, Richard Greil, Tanja Nicole Hartmann
Journal: Blood (2013)
A Phosphodiesterase 4B-Mediated Interplay Between Tumor Cells and the Microenvironment Regulates Angiogenesis in B Cell Lymphoma
Authors: Avvaru Suhasini, Long Wang, Kenneth Holder, An-Ping Lin, Sang-Woo Kim, Harshita Bhatnagar, August Moritz, Ricardo C Aguiar
Journal: Blood (2015)
Phase II Randomized Study of Lenalidomide or Lenalidomide and Rituximab Following Standard Chemotherapy for Patients with Intermediate-High/High Risk Diffuse Large B-Cell Lymphoma (DLBCL) - Final Results
Authors: Nishitha M Reddy, David S Morgan, John P Greer, Heidi Chen, Steven I. Park, Kristy L. Richards
Journal: Blood (2015)
The Synthetic Hest Shock Protein (Hsp) 90 Inhibitor EC141 Induces Degradation of the Bcr-Abl p190 Protein and Apoptosis of Philadelphia Chromosome (Ph)-Positive Acute Lymphoblastic Leukemia (ALL) Cells.
Authors: Alessandra Ferrajoli, Yongtao Wang, Susan M. O’Brien, Stefan H. Faderl, David M. Harris, Quin Van, Inbal Hallevi, Zhiming Liu, Patricia E. Koch, John Sensintaffar, Francis Burrows, Hagop M. Kantarjian, Michael J. Keating, Zeev Estrov
Journal: Blood (2007)
A Phase I Trial of the Anti-Inhibitory KIR Antibody, IPH2101, and Lenalidomide in Multiple Myeloma: Interim Results
Authors: Don M. Benson, Adam D Cohen, Nikhil C. Munshi, Sundar Jagannath, Gary Spitzer, Craig C. Hofmeister, Robert Zerbib, Pascale Andre, Yvonne A Efebera, Shawna Oxier, Michael A. Caligiuri
Journal: Blood (2012)
Receipt of Maintenance Therapy Is Most Predictive of Survival in Older Acute Lymphoblastic Leukemia Patients Treated with Intensive Induction Chemotherapy Regimens.
Authors: Daniel J. Landsburg, Edward A. Stadtmauer, Alison W. Loren, Steven C. Goldstein, Noelle V. Frey, Sunita D. Nasta, David L Porter, Donald E Tsai, Alexander E Perl, Elizabeth Hexner, Selina Luger
Journal: Blood (2012)
Sequential Treatment with the Anti-CD 20 Antibody Rituximab and CHOP+GCSF Chemotherapy in Patients with Post-Transplant Lymphoproliferative Disorder (PTLD): First Interim Analysis of a Multicenter Phase II Study.
Authors: Ralf Trappe, Stephan Oertel, Sylvain Choquet, Vernoique LeBlond, Matthias Papp-Vary, Hanno Riess
Journal: Blood (2005)
Follicular Lymphoma-Like B-Cells in Healthy Individuals: A Novel Intermediate Step in Early Lymphomagenesis.
Authors: Sandrine Roulland, Jean-marc Navarro, Pierre Grenot, Michele Milili, Julie Agopian, Bertrand Montpellier, Pascal Gauduchon, Pierre Lebailly, Claudine Schiff, Bertrand Nadel
Journal: Blood (2006)
The Efficacy of Rasburicase and Rituximab Combined with FAB Chemotherapy in Children and Adolescents with Newly Diagnosed Stage III/IV, BM+ and CNS+ Mature B-NHL: A Children's Oncology Group Report
Authors: Stanton Goldman, Paul J. Galardy, Lynette Smith, Sherrie L. Perkins, Bruce Shiramizu, Thomas Gross, Warren G. Sanger, Lauren Harrison, Mitchell S. Cairo
Journal: Blood (2011)
HLA and TCR Knockout by Zinc Finger Nucleases: Toward “off-the-Shelf” Allogeneic T-Cell Therapy for CD19+ Malignancies.
Authors: Hiroki Torikai, Andreas Reik, Carrie Yuen, Yuanyue Zhou, Denise Kellar, Helen Huls, Edus H. Warren, Scott S. Tykodi, Philip D. Gregory, Michael C. Holmes, Edward J. Rebar, Dean A. Lee, Richard E. Champlin, Chiara Bonini, Laurence Cooper
Journal: Blood (2010)
CCR4:CCL17 Interaction Influences TLR-9 Mediated Cell Survival and Proliferation In Chronic Lymphocytic Leukemia
Authors: Sonal C. Temburni, Ryon M. Andersen, Luke Janson, Xiao-Jie Yan, Barbara Sherry, Matthew Kaufman, Steven L. Allen, Kanti R. Rai, Nicholas Chiorazzi, Rajendra N. Damle
Journal: Blood (2010)
TM-233, a Novel Analog of 1'-Acetoxychavicol Acetate (ACA), Induces Cell Death in Human Myeloma Cells by Inhibiting Both JAK/STAT and NF-κB Pathways: A Possible New Agent for Overcoming Bortezomib-Resistance.
Authors: Morihiko Sagawa, Tatsuki Tomikawa, Tomoe Nemoto, Takayuki Tabayashi, Reiko Watanabe, Michihide Tokuhira, Masaki Ri, Yuichi Hashimoto, Shinsuke Iida, Masahiro Kizaki
Journal: Blood (2012)
A Simple Bundle to Control an Outbreak of Carbapenem-Resistant Enterobacteriacae in an Onco-Hematological Inpatient Unit: Report from a Single Center
Authors: Bruno K L Duarte, Gabriela G Yamaguti Hayakawa, Francisco A Ferreira, Katia B B Pagnano, Erich Vinicius De Paula, Margareth C Ozelo
Journal: Blood (2017)
Extramedullary Erythropoiesis in Spleen of HIF Prolyl 4-Hydroxylase-2 Deficient Mice Is Mediated By Notch Signaling Downregulation
Authors: Mikko Myllymäki, Jenni Määttä, Elitsa Dimova, Valerio Izzi, Timo Väisänen, Johanna Myllyharju, Peppi Koivunen, Raisa Serpi
Journal: Blood (2016)
Multi-Center Phase II Study of CAMPATH-1H Dose De-Escalation Prior to Nonmyeloablative HLA-Identical Sibling Transplantation.
Authors: Ronjon Chakraverty, Nilusha Manji, Richard Clark, Charles Crawley, Peter Johnson, Effie Liakopoulou, Judith Marsh, Donald Milligan, Emma Morris, Karl Peggs, Kirsty Thomson, John Snowden, Graham Jackson, Stephen Mackinnon
Journal: Blood (2007)
Risk factors for atypical hyperplasia of the breast
Authors: Jingfang Cheng, Usha Raju, Sandra R. Wolman, Maria J. Worsham
Journal: Cancer Research (2005)

3232  Atypical breast lesions, including atypical ductal hyperplasia (ADH) and atypical lobular hyperplasia (ALH), carry higher risks of progression to breast cancer than other types of lesions. ADH and ALH are characterized by cells that have acquired some of the neoplastic characteristics of ductal carcinoma in situ or lobular carcinoma in situ, respectively. Risk factors for atypical hyperplasia remain poorly understood. The purpose of this study was to identify risk factors associated with atypical hyperplasia in an epidemiologically well-characterized benign breast disease (BBD) cohort of 4970 primary BBD subjects drawn from a large, multi-ethnic, primary care patient population, diagnosed by surgical biopsies in the Henry Ford Health System from 1981-1994, and followed for 8-21 years after BBD diagnosis. From this primary BBD cohort, 410 subjects (84 African American and 326 white, aged 18-84 years), for whom eligible interview data were available, were sampled to assess the association of risk factors and atypical hyperplasia (AH). The BBD lesions were classified as nonproliferative, proliferative without atypia, or proliferative with AH. Atypical hyperplasia was either ductal (ADH) or lobular (ALH). Of the 410 selected BBD subjects, 24 had AH, inclusive of ADH or ALH, and 386 had non-AH lesions. Risk factors evaluated for this study included race, age, age at menarche, marital status, parity, body mass index, smoking, and the number of BBD lesions. Univariate analysis was performed to calculate odds ratios for each risk factor and its association with AH. Those risk factors with statistical significance were entered into a multivariate logistic regression analysis. We found that multiple lesions were present in 70% of our 4970 person BBD cohort. A subset analysis of 24 BBD patients with AH and 386 BBD without AH indicates that increasing lesion number is an independent factor favoring the presence of atypical hyperplasia. In addition, the multivariate logistic regression analysis indicates that lesion number is associated with an increased incidence of AH independent of age. The finding that AH is increased in women older than 50 years, who may be considered as postmenopausal, supports the concept of progression to breast cancer from BBD with time. Supported by NIH R01 CA 709233
Off-label use of dupilumab for pediatric patients with atopic dermatitis: A multicenter retrospective review
Authors: Sean Igelman, Anastasia O. Kurta, Umar Sheikh, Ashley McWilliams, Eric Armbrecht, Stephanie R. Jackson Cullison, Douglas W. Kress, Anna Smith, Leslie Castelo-Soccio, James Treat, William D. Boothe, Lucia Z. Diaz, Moise L. Levy, Avni Patel, Lara Wine Lee, M. Carmen Fraile-Alonso, Richard J. Antaya, Sonal Shah, Nicole Kittler, Lisa Arkin, Elaine Siegfried
Journal: Journal of the American Academy of Dermatology (2019)
Acute Gvhd Induce the Critical Depletion of Naïve Pool in Regulatory T Cells: Implication for Linked Pathogenesis into Chronic Gvhd
Authors: Takanori Yoshioka, Yusuke Meguri, Takeru Asano, Yuriko Kishi, Miki Iwamoto, Yoshinobu Maeda, Mitsune Tanimoto, Ken-Ichi Matsuoka
Journal: Blood (2015)
Extrahepatic manifestations of hepatitis E virus: An overview
Authors: Fotios S. Fousekis, Ioannis V. Mitselos, Dimitrios K. Christodoulou
Journal: Clinical and Molecular Hepatology (2019)

Hepatitis E virus (HEV) is a significant health problem with approximately 20 million individuals infected annually. HEV infection has been associated with a wide spectrum of extrahepatic manifestations, including neurological, hematological and renal disorders. Guillain-Barré syndrome and neuralgic amyotrophy are the most frequent neurological manifestations. In addition, HEV infection has been observed with other neurological diseases, such as encephalitis, myelitis and Bell's palsy. Hematologic manifestations include anemia due to glucose-6-phospate dehydrogonase deficiency, autoimmune hemolytic anemia and severe thrombocytopenia. Membranoproliferative glomerulonephritis and relapse IgA nephropathy with or without coexisting cryoglobulinemia appear to be the most common renal injuries related with HEV infection. Also, HEV infection has been associated with acute pancreatitis and other immune-mediated manifestations, such as arthritis and myocarditis. However, the pathophysiologic mechanisms of HEV-related extrahepatic manifestations are still largely unclear. Keywords: Hepatitis E; Kidney; Neurologic manifestations; Hematologic diseases
Delineation of Canonical and Non-Canonical NF-κB Pathways in Multiple Myeloma: Therapeutic Implications.
Authors: Teru Hideshima, Noopur Raje, Ruben Carrasco, Hiroshi Ikeda, Yutaka Okawa, Tanyel Kiziltepe, Sonia Valet, Samantha Pozzi, Dharminder Chauhan, Constantine Mitsiades, Klaus Podar, Yu-Tzu Tai, Nikhil C. Munshi, Paul G. Richardson, Kenneth C. Anderson
Journal: Blood (2007)
Mature Results of a Prospective Trial of Rituximab in Patients (Pt) with Post Transplant Lymphoproliferative Disorder (PTLD) Unresponsive or Ineligible for Reduced Immunosuppression (RIS).
Authors: Jeff P. Sharman, Donald E. Tsai, Clare J. Twist, Steven M. Horwitz, Carol D. Jones, Sandra J. Horning
Journal: Blood (2006)
FoxO Transcription Factor Is Delocalized and Inactivated in Acute Myeloid Leukaemia Patients.
Authors: Daniela Cilloni, Cristina Panuzzo, Francesca Messa, Francesca Arruga, Paolo Nicoli, Emanuela Messa, Sonia Carturan, Ilaria Defilippi, Ilaria Iacobucci, Valentina Rosso, Giovanni Martinelli, Enrico Bracco, Giuseppe Saglio
Journal: Blood (2007)
Exploratory analysis of JFCM: Predictive value of rash, EGFR expression, and EGFR copy for necitumumab in squamous NSCLC
Authors: Yasushi Goto, Makoto Nishio, Nobuyuki Yamamoto, Yuichiro Ohe, Ami Kamada, Kazumi Suzukawa, Sotaro Enatsu, Kazuhiko Nakagawa, Tomohide Tamura
Journal: Annals of Oncology (2019)
Absolute Quantification of EVI1 Overexpression in Acute Myeloid Leukemia By RQ-PCR Analysis : A Study of the ALFA Group
Authors: Thomas Smol, Aline Renneville, Olivier Nibourel, Alice Marceau-Renaut, Karine Celli-Lebras, Céline Berthon, Bruno Quesnel, Nicolas Boissel, Christine Terré, Xavier Thomas, Sylvie Castaigne, Hervé Dombret, Claude Preudhomme
Journal: Blood (2014)
Concurrent or Sequential BCR-ABL Translocation and Calr gene or JAK2V617F Mutation
Authors: Maria Pagoni, Maria Garofalaki, Irene Tziotziou, Evaggelia Nikolou, Stamatis Karakatsanis, Ioannis Tsonis, Katerina Zoi, Ioannis Baltathakis, Dimitrios Karakasis, Nikolaos Harhalakis
Journal: Blood (2014)
Glycogen synthase kinase 3β hyperactivity in urinary exfoliated cells predicts progression of diabetic kidney disease
Authors: Xianhui Liang, Pei Wang, Bohan Chen, Yan Ge, Athena Y. Gong, Bryce Flickinger, Deepak K. Malhotra, Li Juan Wang, Lance D. Dworkin, Zhangsuo Liu, Rujun Gong
Journal: Kidney International (2019)

Burgeoning evidence points to glycogen synthase kinase (GSK)3β as a key player in diverse kidney diseases. However, as a pivotal transducer of the insulin signaling pathway, the role of GSK3β in diabetic kidney disease remains uncertain. In db/db mice, renal expression of total and activated GSK3β was increasingly elevated. This preceded the development of diabetic kidney disease, and correlated with the progression of signs of diabetic kidney injury, including albuminuria and extracellular matrix accumulation in glomeruli and tubulointerstitia. In vitro, exposure of glomerular podocytes, mesangial cells, and renal tubular cells to a diabetic milieu induced GSK3β overexpression and hyperactivity, which seem essential and sufficient for eliciting diabetic cellular damages in kidney cells, because the cytopathic effect of the diabetic milieu was mitigated by GSK3β knockdown, but was mimicked by ectopic expression of constitutively active GSK3β even in the normal milieu. In consistency, kidney biopsy specimens procured from patients with varying stages of diabetic nephropathy revealed an amplified expression of total and activated GSK3β in glomeruli and renal tubules, associated with the severity of diabetic nephropathy. Moreover, in retrospective cohorts of type 2 diabetic patients that were followed for over five years, the relative activity of GSK3β in banked urinary exfoliated cells represented an independent risk factor for development or progression of renal impairment. Furthermore, receiver operating characteristic curve analysis demonstrated that GSK3β activity in urinary exfoliated cells provided much better power than albuminuria in discriminating diabetic patients with progressive renal impairment from those with stable kidney function. Thus, renal expression and activity of GSK3β are amplified in experimental and clinical diabetic nephropathy. Hence, GSK3β in urinary exfoliated cells may serve as a novel biomarker for predicting diabetic kidney disease progression.
A Network Of Epigenetic Regulators Guide Developmental Hematopoiesis In Vivo
Authors: Katie L Kathrein, Hsuan-Ting Huang, Abby Barton, Zachary Gitlin, Yue-Hua Huang, Thomas P Ward, Oliver Hofmann, Anthony DiBiase, Anhua Song, Svitlana Tyekucheva, Winston Hide, Yi Zhou, Leonard I. Zon
Journal: Blood (2013)
Results of the Japanese Childhood Acute Myeloid Leukemia 99 Protocol for Down Syndrome and Acute Myeloid Leukemia.
Authors: Kazuko Kudo, Seiji Kojima, Ken Tabuchi, Eisaburo Ishii, Hiromasa Yabe, Akio Tawa, Masue Imaizumi, Ryoji Hanada, Kazuko Hamamoto, Ryoji Kobayashi, Akira Morimoto, Hideki Nakayama, Shigeru Tsuchiya, Masahiro Tsuchida, Keizo Horibe, Ichiro Tsukimoto
Journal: Blood (2005)
The Mutational Landscape of CTCL and Sezary Syndrome
Authors: Teresa Palomero, Ana Carolina da Silva Almeida, Francesco Abate, Hossein Khiabanian, Estela Martinez-Escala, Joan Guitart, Cornelis P Tensen, Maarten H. Vermeer, Raul Rabadan, Adolfo A. Ferrando
Journal: Blood (2015)
Detection of Clonal Hematopoiesis in Cytopenic Patients Using Targeted Sequencing
Authors: Eric J. Duncavage, Jennifer O'Brien, Kiran R. Vij, Chris A Miller, Jin Shao, Meagan A. Jacoby, Robert S. Fulton, Sharon Heath, Megan Janke, Catrina C. Fronick, Michelle O'Laughlin, Richard K Wilson, Timothy J. Ley, Matthew J. Walter
Journal: Blood (2015)
Classification of HLA-Matching for Retrospective Analysis of Unrelated Donor Transplantation: Revised Definitions To Predict Survival.
Authors: Daniel J. Weisdorf, Stephen Spellman, John Klein, Michael D. Haagenson, Mary Horowitz, Stephanie Lee, Claudio Anasetti, Michelle Setterholm, Rebecca Drexler, Martin Maiers, Roberta King, Dennis Confer
Journal: Blood (2007)
Front-Line Therapy with Rituximab, Cyclophosphamide, Vincristine, and Prednisone (R-CVP) Followed by 2 Years of Rituximab Maintenance for Follicular Lymphoma (FL) Is Associated with Excellent Outcomes and Improved Progression-Free Survival (PFS) In Comparison to No Maintenance
Authors: Alden A. Moccia, Paul Hoskins, Richard Klasa, Kerry J. Savage, Tamara Shenkier, Graham W. Slack, Randy D. Gascoyne, Joseph M. Connors, Laurie H. Sehn
Journal: Blood (2010)
Association of Indiana’s Section 1115 Waiver With Medicaid Enrollment
Authors: Jim P. Stimpson, Yang Wang, Fernando A. Wilson
Journal: JAMA Network Open (2019)

states that expanded Medicaid without a waiver.The parallel trends assumption for the difference-indifferences analysis was met through the regression estimator (F = 1.11;P = .34). DiscussionThis cross-sectional study found that Indiana's waiver was associated with negative enrollment gains relative to full Medicaid expansion.Our results should be interpreted within the limitation that our estimates of Medicaid coverage are measured in annual increments that are based on the respondent's insurance coverage at the time of the survey rather than variation within the year. 5 Evaluation of Medicaid expansion waivers is complex and requires greater attention as states use these waivers to both expand Medicaid and modify the original intention of the program to increase access to care. 2 However, it should be emphasized that use of waivers gave states the political leverage to expand Medicaid, which reduced the overall unisurance rate.The potential for a negative impact on Medicaid enrollment relative to full Medicaid expansion should be considered by policy makers, especially in states that have not yet expanded Medicaid or in states that used or are considering using Section 1115 waivers.